Nature Biotechnology
Volume 38 Issue 7, July 2020
https://www.nature.com/nbt/volumes/38/issues/7

Editorial | 08 July 2020
The clinical cutting edge
As CRISPR–Cas9 enters human testing, the blistering pace of progress in preclinical research is offering a bewildering array of options for therapeutic gene editing.